Atacand filed for heart failure in US

July 8, 2004

AstraZeneca has submitted its cardiovascular drug Atacand for an additional US licence to treat heart failure.Atacand (candesartan) is one of …

Pfizer’s next blockbuster Lyrica receives European approval

July 8, 2004

Pfizer's potential central nervous system blockbuster Lyrica (pregabalin) has received European marketing approval.The drug has received licences for the treatment …

Pfizer UK recruiting for new customer-focused salesforce

July 8, 2004
NHS, Pfizer, salesforce

 Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …

Everyday diseases and everyday solutions

July 8, 2004

What is all the fuss about chronic disease management? Go to virtually any NHS conference these days and you will …

Growing doubts over reliability of HRT trial conclusions

July 6, 2004

Influential publicly-funded trials into HRT which convinced millions of women to stop taking the treatment could be flawed, researchers from …

Labour stakes its reputation on NHS Plan part II

July 6, 2004

The government has unveiled a plan for the second half of the 10-year period covered by the NHS Plan, claiming …

Unveiled: how to win their attention

July 2, 2004

Sir Arthur Conan Doyle once wrote: "It is a capital mistake to theorise before one has data. Insensibly one begins …

Takeda to launch ‘radically different’ approach to NHS

July 2, 2004
NHS, Takeda, salesforce

 Takeda UK has unveiled plans for what it calls a ‘radically different’ structure to its sales operations designed to liberate …

Novartis rivals find VALUE in landmark Diovan trial

July 1, 2004

A landmark study comparing Novartis' Diovan with Pfizer's calcium channel blocker Istin has ended with both sides claiming superiority for …

Pharma’s reputation continues to slide

July 1, 2004

The reputation of the pharmaceutical industry in the US continues to decline as the public grows increasingly concerned about the …

Fast4wD expands clinical trial focus

July 1, 2004

Ogilvy Public Relations Worldwide and Shire Health Group have merged part of their operations to form Fast4wD Ogilvy, a clinical …

US parallel trade to be legalised after Republican U-turn

June 29, 2004

Re-importation of cheaper medicines from Canada and other countries into the US looks certain to be legalised after the Bush …

Sanofi executives take control of new boardroom

June 24, 2004

The soon to be created Sanofi-Aventis will be dominated by executives from Sanofi-Synthelabo who have pledged to deliver "swift integration" …

GlaxoSmithKline to publish trial data online

June 24, 2004

GlaxoSmithKline has announced it is to make data from all of its trials available online in an effort to counter …

Contract research looks East

June 24, 2004

Contract research organisations (CRO) have benefited from the pressure on the pharmaceutical industry to maintain a flow of blockbusters at …

Study finds dementia risk for HRT

June 24, 2004

A new study has found that both oestrogen-only and oestrogen plus progestogen hormone replacement therapies may increase the risk of …

Positive opinion on Raptiva in Europe

June 24, 2004

Raptiva, a new psoriasis treatment to be marketed by Serono in Europe has gained a positive opinion from the EMEA.The …

The Gateway to Local Adoption Series

Latest content